US9573961, Example 89

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: US9573961, Example 89
• 英文别名: 5-[(3R,9aS)-8-[6-(tetrazol-1-yl)-1,2,3,4-tetrahydronaphthalene-1-carbonyl]-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-3-yl]-4-methyl-3H-2-benzofuran-1-one
• 化学式: C₂₈H₃₀N₆O₄
• 分子量: 514.6
• InChiKey: JCELYMYSGQSAHG-RZFHSFIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  38
• 可旋转键数：
  3
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  103
• 氢给体数：
  0
• 氢受体数：
  8

文献信息

• Inhibitors of the Renal Outer Medullary Potassium Channel
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20150329557A1

  公开（公告）日：2015-11-19

  The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.

  本发明提供了I式化合物及其药学上可接受的盐，它们是ROMK（Kir1.1）通道的抑制剂。这些化合物可用作利尿剂和/或钠利尿剂，并用于治疗和预防包括高血压、心力衰竭和与过度盐和水潴留有关的医疗条件在内的心血管疾病。
• INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP2934533B1

  公开（公告）日：2017-11-15
• US9573961B2
  申请人：——

  公开号：US9573961B2

  公开（公告）日：2017-02-21
• [EN] INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL<br/>[FR] INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTERNE RÉNAL
  申请人：MERCK SHARP & DOHME

  公开号：WO2014099633A2

  公开（公告）日：2014-06-26

  The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kirl.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.